Bio-Rad Laboratories Inc. (BIOB) Financial Statements (2025 and earlier)

Company Profile

Business Address 1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,6651,6071,7918709911,115
Cash and cash equivalent488404434471662661
Short-term investments1,1761,2031,356399329454
Restricted cash and investments  66666
Receivables453489495424419393
Inventory, net of allowances, customer advances and progress billings760781719572622554
Inventory760781719572622554
Prepaid expense12314012410891102
Other current assets312624101111
Total current assets:3,0303,0483,1581,9892,1402,180
Noncurrent Assets
Operating lease, right-of-use asset161195181205202202
Property, plant and equipment 528529499491491499
Long-term investments and receivables4,8397,6988,83114,3879,5614,638
Long-term investments4,8397,6988,83114,3879,5614,638
Intangible assets, net (including goodwill)704734739601491410
Goodwill411414406347292264
Intangible assets, net (excluding goodwill)294321332254199146
Restricted cash and investments      
Other noncurrent assets 10295951038780
Other undisclosed noncurrent assets      
Total noncurrent assets:6,3349,25110,34415,78710,8335,829
TOTAL ASSETS:9,36412,29913,50217,77612,9738,009
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities278320362465420315
Taxes payable465728
Employee-related liabilities277223180
Accounts payable122145135142139107
Accrued liabilities155176227   
Deferred revenue   52514234
Debt10114462
Deferred compensation liability   14  
Other liabilities14716211712813187
Other undisclosed current liabilities42403432349
Total current liabilities:468523569681632905
Noncurrent Liabilities
Long-term debt and lease obligation, including:1,2001,1991,198111214
Long-term debt, excluding current maturities1,2001,199    
Finance lease, liability 91010111111
Other undisclosed long-term debt and lease obligation (9)(10)1,188(176)(174)(174)
Liabilities, other than long-term debt1,1271,8362,1203,3152,369241
Deferred income tax liabilities8181,4751,7703,0592,077 
Liability, pension and other postretirement and postemployment benefits    749580
Other liabilities177195196182197161
Operating lease, liability131165154176175176
Other undisclosed noncurrent liabilities    102801,093
Total noncurrent liabilities:2,3273,0353,3183,4282,4611,348
Total liabilities:2,7953,5583,8864,1093,0932,254
Equity
Equity, attributable to parent, including:6,5698,7419,61513,6679,8805,755
Treasury stock, value (772)(633)    
Additional paid in capital463449447442429410
Accumulated other comprehensive income (loss)(538)(336)(467)(176)282(87)
Retained earnings7,4169,2619,89813,5079,2685,471
Other undisclosed equity, attributable to parent 0(264)(106)(100)(38)
Total equity:6,5698,7419,61513,6679,8805,755
TOTAL LIABILITIES AND EQUITY:9,36412,29913,50217,77612,9738,009

Income Statement (P&L) ($ in millions)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues2,5672,6712,8022,9232,5462,312
Cost of revenue
(Cost of Product and Service Sold)
(1,188)(1,244)(1,235)(1,282)(1,108)(1,055)
Other undisclosed gross profit  (0)000(0)
Gross profit:1,3791,4271,5671,6411,4381,257
Operating expenses(1,110)(1,089)(1,085)(1,151)(1,027)(1,027)
Operating income:269338483489411230
Nonoperating income9411445242324
Other nonoperating income9010645272426
Interest and debt expense(1)(49)(38)(2)(22)(23)
Other undisclosed income from continuing operations before equity method investments, income taxes     4,4962,031
Income from continuing operations before equity method investments, income taxes:3634024895124,9082,261
Other undisclosed income (loss) from continuing operations before income taxes(2,705)(1,252)(5,194)4,926  
Income (loss) from continuing operations before income taxes:(2,343)(850)(4,704)5,4384,9082,261
Income tax expense (benefit)4982131,077(1,192)(1,101)(502)
Income (loss) from continuing operations:(1,844)(637)(3,628)4,2463,8061,759
Income before gain (loss) on sale of properties:4,2463,8061,759
Net income (loss) available to common stockholders, diluted:(1,844)(637)(3,628)4,2463,8061,759

Comprehensive Income ($ in millions)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):(1,844)(637)(3,628)4,2463,8061,759
Other comprehensive income (loss)(202)131(291)(458)370(40)
Comprehensive income (loss), net of tax, attributable to parent:(2,046)(507)(3,919)3,7884,1761,718

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: